Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neucardin in Chronic Systolic Heart Failure
NCT01214096Phase 3Terminated
- Sponsor
- Zensun
- Start
- Jul 2010
- Primary completion
- Jan 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neucardin in chronic systolic heart failure (HFrEF) (4 arms), sponsored by Zensun. Primary endpoint: Cardiac Function measured by MRI at 30 days. Started Jul 2010; status: terminated.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT01214096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214096.